Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Epidemiology of seropositive myasthenia gravis in Greece
Autore:
Poulas, K; Tsibri, E; Kokla, A; Papanastasiou, D; Tsouloufis, T; Marinou, M; Tsantili, P; Papapetropoulos, T; Tzartos, SJ;
Indirizzi:
Hellenic Pasteur Inst, Dept Biochem, Athens 11521, Greece Hellenic PasteurInst Athens Greece 11521 Biochem, Athens 11521, Greece Reg Univ Hosp Patras, Med Sch Patras, Dept Neurol, Rion 26500, Greece Reg Univ Hosp Patras Rion Greece 26500 , Dept Neurol, Rion 26500, Greece
Titolo Testata:
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
fascicolo: 3, volume: 71, anno: 2001,
pagine: 352 - 356
SICI:
0022-3050(200109)71:3<352:EOSMGI>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
DENMARK;
Keywords:
myasthenia gravis; neuromuscular disease; epidemiology;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
26
Recensione:
Indirizzi per estratti:
Indirizzo: Tzartos, SJ Hellenic Pasteur Inst, Dept Biochem, 127 Vas Sofias Ave, Athens 11521, Greece Hellenic Pasteur Inst 127 Vas Sofias Ave Athens Greece 11521
Citazione:
K. Poulas et al., "Epidemiology of seropositive myasthenia gravis in Greece", J NE NE PSY, 71(3), 2001, pp. 352-356

Abstract

Objectives-To study the epidemiological characteristics of myasthenia gravis in Greece. Methods-A population based study was carried out of seropositive myasthenia. gravis in Greece for the period from 1 January 1983 to 30 June 1997; 843patients were studied. Results-The average annual incidence for the period 1992-7, for which the database is complete, was 7.40/million population/year (women 7.14; men 7.66). On 1 July 1997, there were 740 prevalent cases. The point prevalence rate was 70.63/million (women 91.58; men 59.39). The average overall annual mortality rate in the patients was 0.67/million population (women 0.53; men 0.82), arid the mortality rate attributed to myasthenia gravis was 0.43/million population (women 0.41; men 0.45). The average age at onset was 46.50 years (women 40.16; men 54.46), and the mean age of the prevalent patients was 52.58 (women 47.65; men 59.48). The women:men incidence ratio was 1:1.04, and the prevalence ratio was 1.41:1. It is predicted that the prevalenceand women: men prevalence ratio would increase if the patient list included all patients with a date of onset before 1983. Conclusions-The largest epidemiological study ever performed on myastheniagravis is presented. The most important epidemiological indexes are provided.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/09/20 alle ore 04:42:05